Biotech

Chembio Files Final Module of Premarket Approval Application With FDA for DPP(R) Point-of-Care HIV 1/2 Rapid Test

MEDFORD, NY: ...

International Patent Application Submitted for the Therapeutic and Potentially Preventive Vaccine Vacc-HIV, Combining Bionor's Vacc-4x and Vacc-C5

OSLO, NORWAY: ...

West Announces Expiration and Final Results of Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047

LIONVILLE, PA: ...

Bio-Matrix' Regen BioPharma Unit Establishes Scientific Advisory Board and Research Relationship With Clinartis in Anticipation of Beginning Clinical Development Stem Cell Studies

SAN DIEGO, CA: ...

Medivation and Astellas Provide Update on PREVAIL Enrollment

SAN FRANCISCO, CA and TOKYO: ...

Newest Release of Advanced Pharma CRM on iPad and Android(TM) Available From StayinFront

FAIRFIELD, NJ: New Features Added to StayinFront TouchRx(R) to Further Improve Effectiveness of Field Teams ...

Mediatum Hosts 11th Annual Executive Forum for Life Sciences Decision-Makers

CAMBRIDGE, MA: Over 100 Life Sciences Executives Gathered in Germany for Networking, Insightful Discussion and the Exchange of Ideas ...

The Medicines Company Announces Intention to Offer $200 Million of Convertible Notes

PARSIPPANY, NJ: ...

Enzon Presents Final Analysis of Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer at 2012 ASCO Meeting

PISCATAWAY, NJ: ...

SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits of TREAKISYM(R) (Bendamustine) in Combination With Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

TOKYO: Multicenter Phase II Study Reports ORR of 63% With a 37% CR Rate; Median PFS of 6.7 Months ...